Remarkably, many proteins that frequently display quantitative changes in cancer patients, such as cytokines/chemokines [52], extracellular matrix proteins [53], coagulation factors [54], complement factors [55], immunoglobulins [56], and albumin [57], can interact with EVs after their release and change their composition [51]. Here, ALB is linked to cancer.